Despite recommended prophylaxis, symptomatic VTE occurs in approximately 1% of knee and 0.5% of hip arthroplasty patients before hospital discharge.
Answers are grounded in this paper and cite their sources.
Early symptomatic VTE persists after arthroplasty despite prophylaxis; leaves open whether intensified regimens reduce events in routine care.
Using current VTE prophylaxis, approximately 1 in 100 patients undergoing TPKA and approximately 1 in 200 patients undergoing TPHA develops symptomatic VTE prior to hospital discharge.
No takes yet. Share an insight, caveat, or question.
Januel et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: